Enzo Clinical Labs Kara Cannon
2020
In 2020, Enzo Clinical Labs Kara Cannon earned a total compensation of $371.3K as Chief Commercial Officer at Enzo Biochem, a 2% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $60,000 |
|---|---|
| Option Awards | $49,000 |
| Salary | $220,000 |
| Stock Awards | $29,260 |
| Other | $13,052 |
| Total | $371,312 |
Cannon received $220K in salary, accounting for 59% of the total pay in 2020.
Cannon also received $60K in non-equity incentive plan, $49K in option awards, $29.3K in stock awards and $13.1K in other compensation.
Rankings
In 2020, Enzo Clinical Labs Kara Cannon's compensation ranked 11,731st out of 13,090 executives tracked by ExecPay. In other words, Cannon earned more than 10.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,731 out of 13,090 | 10th |
Division Services | 2,114 out of 2,338 | 10th |
Major group Health Services | 232 out of 252 | 8th |
Industry group Medical And Dental Laboratories | 67 out of 73 | 8th |
Industry Medical Laboratories | 67 out of 73 | 8th |
Source: SEC filing on November 27, 2020.
Cannon's colleagues
We found four more compensation records of executives who worked with Enzo Clinical Labs Kara Cannon at Enzo Biochem in 2020.